An Imidazo[2,1‐b][1,3,4]thiadiazole Derivative Inhibits the Virulence Factor α‐Hemolysin by Blocking the Pullout of Its Stem Domain

Documenti analoghi

• Investigating the C2 Modulation of the Imidazo[1,2‐a]pyrazine‐Based Hit Compound CTN1122: Synthesis, in vitro Antileishmanial Activity, Cytotoxicity and Casein Kinase 1 Inhibition
  di: Lhana Tisseur, et al.
  Pubblicazione: (2025)
• Synthesis, Biological Evaluation, and Interaction with Calf Thymus‐DNA of Mono‐ and Diamidino‐Substituted Imidazo[4,5‐ b ]pyridines
  di: Ida Boček Pavlinac, et al.
  Pubblicazione: (2025)
• Design, Synthesis, and In Vitro and In Silico Evaluation of 1,3,4‐Oxadiazoles as Anti‐Trypanosoma cruzi and Anti‐Leishmania mexicana Agents
  di: Timoteo Delgado‐Maldonado, et al.
  Pubblicazione: (2024)
• Design and Discovery of Substituted 1,3,4‐Thiadiazole–1,3,5‐Triazine Hybrids as Human Immunodeficiency Virus‐1 Non‐Nucleoside Reverse Transcriptase Inhibitors with Anti‐SARS‐CoV‐2 and Antibacterial Activities
  di: Saumya Singh, et al.
  Pubblicazione: (2026)
• Targeting Plasmodium falciparum Single‐Stranded DNA‐Binding Protein: Discovery of New Scaffold Compounds Effective against Drug‐Sensitive and Artemisinin‐Resistant Strains
  di: Biswajit Naik, et al.
  Pubblicazione: (2025)